Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.
about
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicologyVariability in aflatoxin-albumin adduct levels and effects of hepatitis B and C virus infection and glutathione S-transferase M1 and T1 genotype.Metabolism and biomarkers of heterocyclic aromatic amines in molecular epidemiology studies: lessons learned from aromatic aminesBiomonitoring Human Albumin Adducts: The Past, the Present, and the FutureDetermination of urinary biomarkers for assessment of short-term human exposure to aflatoxins in São Paulo, BrazilDevelopment of aflatoxin B(1)-lysine adduct monoclonal antibody for human exposure studies.Aflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in Taiwan.Calcium montmorillonite clay reduces AFB1 and FB1 biomarkers in rats exposed to single and co-exposures of aflatoxin and fumonisinHuman aflatoxin exposure in Kenya, 2007: a cross-sectional study.Molecular epidemiology in cancer risk assessment and prevention: recent progress and avenues for future research.Characterization of various classes of protein adducts.Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus.Significance of DNA adduct studies in animal models for cancer molecular dosimetry and risk assessment.Does aflatoxin exposure in the United Kingdom constitute a cancer risk?Dietary aflatoxin exposure and chemoprevention of cancer: a clinical review.Mass Spectrometric Characterization of Human Serum Albumin Adducts Formed with N-Oxidized Metabolites of 2-Amino-1-methylphenylimidazo[4,5-b]pyridine in Human Plasma and HepatocytesMercapturic acids, protein adducts, and DNA adducts as biomarkers of electrophilic chemicals.Present and future directions of translational research on aflatoxin and hepatocellular carcinoma. A review.Determinants of formation of aflatoxin-albumin adducts: a seven-township study in TaiwanLong-term stability of human aflatoxin B1 albumin adducts assessed by isotope dilution mass spectrometry and high-performance liquid chromatography-fluorescenceHepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinomaThe molecular epidemiology of chronic aflatoxin driven impaired child growth.Global DNA methylation in a population with aflatoxin B1 exposure.Drug-protein conjugation and its immunological consequences.The role of biomarkers in evaluating human health concerns from fungal contaminants in food.Exposure measurement of aflatoxins and aflatoxin metabolites in human body fluids. A short review.Longitudinal evaluation of aflatoxin exposure in two cohorts in south-western Uganda.The use of biological markers in toxicology.Chronic aflatoxin exposure in children living in Bhaktapur, Nepal: Extension of the MAL-ED study.Aflatoxin biomarkers in hair may facilitate long-term exposure studies.Characterisation of aflatoxin and deoxynivalenol exposure among pregnant Egyptian women.Hepatocellular carcinoma and food contamination: aflatoxins and ochratoxin A as a great prompter.Advances in Mycotoxin Research: Public Health Perspectives.Aflatoxin-albumin adducts and correlation with decreased serum levels of vitamins A and E in an adult Ghanaian population.Comparison of urinary aflatoxin M1 and aflatoxin albumin adducts as biomarkers for assessing aflatoxin exposure in Tanzanian children.Risk assessment of aflatoxins in food in Africa.Evidence for human antibodies that recognize an aflatoxin epitope in groups with high and low exposure to aflatoxins.Investigation of Non-Covalent Interactions of Aflatoxins (B1, B2, G1, G2, and M1) with Serum Albumin.NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine.Refinement of a Methodology for Untargeted Detection of Serum Albumin Adducts in Human Populations.
P2860
Q24617120-CCE3D5CB-9027-4F78-8D4C-8ED7A007EDCBQ24813065-03FC7D10-1898-4FDD-AC0A-02B1154AFFD4Q28391158-13BC6748-8AB9-4767-BE29-77CC5FEF3A11Q28468289-06EE1F02-1FA0-4CB5-9B9E-F6BFFCFBB850Q33963127-1D527E7C-092C-469C-AAFD-E3F0F5FE246FQ33989690-FCAE3840-6B0C-4E77-B98D-DA6D8E34AA1AQ34605245-8F9A9307-BD36-4FC4-8B35-8D27ED6F92FEQ34652372-9688AF9A-7582-45E7-9192-6AE57E494AC3Q34773557-3B491722-DB5A-4A2A-9D1D-6F9089E154B7Q34844361-FEB6DA7F-106D-4E55-A9DD-14872BE4DDF3Q35031492-42C76729-91AB-4C6F-A5FF-07A8E8B4E26DQ35031497-43309A6F-0BE1-447F-AA51-971A066FE903Q35031566-B5A29BB3-E7F1-4D33-9F1F-097CC16E430FQ35031585-FD60D8F3-3D55-40C1-BE49-592FE063AF87Q35122480-8DBED16D-48EC-4EEF-BFCD-3E16F04FA741Q35624925-62EE3721-71A3-4A15-A6E0-8A9B641A4255Q35662749-A9761D45-AA0F-4BF1-92F1-F80334ADA083Q36318656-639C97BD-4E9B-4215-BB27-E159522CF4C5Q36624396-47A85D56-31F8-4A75-94A4-4A26F8D72695Q36982503-1C57C1EE-94E2-4BAC-AAAF-E66247F22602Q37177567-4DBBA27B-F612-4AF1-AD34-4247FE805F9EQ37437159-0D295EA2-5B49-4B25-9299-7117CA4E48A1Q37445245-E4F4CCB1-D921-4878-9FBC-610621F03B4BQ37944829-42A798B4-AE7D-4C40-A44A-853D90FA60B5Q38014991-368DB3F9-28ED-4A99-9934-CBC6905F1AB3Q38100733-AC238B3C-E186-4F00-80C8-8203EA008AB4Q38385295-B77FC9BF-29BE-4E8D-90E9-29D3BD607BC0Q38729541-C5546A69-A1CA-4F5A-9EF6-3F45F89E0B04Q38924541-515CC9D8-14C2-4916-8651-85B3070BA101Q39281969-F05331BD-1FCE-4F06-ADF1-D2B180139EACQ39355569-62C6A570-B557-4703-B52A-3D7746F5889EQ39387660-776BC55D-177E-4A4D-98D8-9993B0A66E96Q40324481-F9020CD5-76E1-40BB-B536-455A7ADD3A74Q43826973-595829AD-92AB-41FB-98FE-33658CB6074AQ43926412-02DCD611-808C-464C-A493-9206FFDE37CDQ45341937-A3B1BCDB-E777-442C-A77A-CB147195C577Q46175028-2BDCB6B9-EB66-48A8-9D7F-7B114B1FAEA6Q46275221-278BC055-F37F-4E34-A4EF-3A93FEE9D932Q46473464-FF1C5E88-C649-40AE-8691-DE4271BF2A5FQ47141423-3838B892-A1FC-4641-8CDF-31A1DA5D136C
P2860
Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1.
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年学术文章
@wuu
1988年学术文章
@zh
1988年学术文章
@zh-cn
1988年学术文章
@zh-hans
1988年学术文章
@zh-my
1988年学术文章
@zh-sg
1988年學術文章
@yue
1988年學術文章
@zh-hant
name
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@en
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@nl
type
label
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@en
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@nl
prefLabel
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@en
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@nl
P2093
P356
P1433
P1476
Serum albumin adducts in the m ...... ary excretion of aflatoxin M1.
@en
P2093
Groopman JD
Skipper PL
Tannenbaum SR
P304
P356
10.1093/CARCIN/9.7.1323
P407
P577
1988-07-01T00:00:00Z